Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
5(24%)
Results Posted
13%(1 trials)
Terminated
1(5%)

Phase Distribution

Ph not_applicable
2
10%
Ph phase_3
3
14%
Ph phase_1
5
24%
Ph phase_4
6
29%
Ph phase_2
5
24%

Phase Distribution

5

Early Stage

5

Mid Stage

9

Late Stage

Phase Distribution21 total trials
Phase 1Safety & dosage
5(23.8%)
Phase 2Efficacy & side effects
5(23.8%)
Phase 3Large-scale testing
3(14.3%)
Phase 4Post-market surveillance
6(28.6%)
N/ANon-phased studies
2(9.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

5

trials recruiting

Total Trials

21

all time

Status Distribution
Active(5)
Completed(8)
Terminated(2)
Other(6)

Detailed Status

Completed8
unknown6
Recruiting5
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
5
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (23.8%)
Phase 25 (23.8%)
Phase 33 (14.3%)
Phase 46 (28.6%)
N/A2 (9.5%)

Trials by Status

unknown629%
withdrawn15%
completed838%
terminated15%
recruiting524%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT06231758Phase 3

Metformin Safety and Efficacy in Osteoarthritis.

Recruiting
NCT03026140Phase 2

Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer

Recruiting
NCT07246278Phase 1

Celecoxib in Parkinson Disease as Adjuvant Therapy

Recruiting
NCT05962957Phase 2

Role of Pentoxifylline and Celecoxib in Parkinsonism

Completed
NCT03643744Phase 1

Photodynamic Therapy-Induced Immune Modulation: Part III

Terminated
NCT05434065Phase 2

Effects and Mechanisms of Celecoxib on Intracerebral Hemorrhage

Recruiting
NCT05637086Phase 2

Clinical Study Evaluating Safety of Pentoxifylline and Celecoxib in Patients With Grand-Mal Epilepsy Treated by Phenytoin Monotherapy

Recruiting
NCT05512013Phase 1

The Effects of NSAIDs on Bone Metabolism Following Exercise

Completed
NCT05765747Not Applicable

Effectiveness of Yunnan Baiyao in Improving Fracture Pain

Unknown
NCT05436678Phase 1

A Multiple-Dose PK Study to Evaluate the Comparative Bioavailability of PrimeC Tablets to Ciprofloxacin Tablets Co-administered With Celecoxib Capsules, in Healthy Adult Subject

Completed
NCT05232461Phase 1

A Pilot Study to Evaluate the PK Profile of PrimeC-ER Tablets in Healthy Adult Subjects

Completed
NCT05327751Phase 3

Possible Protective Effect of Celecoxib Against Capecitabine Induced Hand and Foot Syndrome in Patients With Colorectal Cancer

Unknown
NCT03586934Phase 3

Multimodal Analgesia in Shoulder Arthroplasty

Withdrawn
NCT03850587Phase 2

Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee

Completed
NCT03464552Phase 4

Celecoxib in Colposcopic Directed Biopsy

Completed
NCT04259333Phase 4

Celecoxib vs. Acetaminophen/Codeine/Caffeine for Post-operative Analgesia in Rhinoplasty.

Unknown
NCT03067194Phase 4

The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis Patients

Completed
NCT04020588Phase 4

Anti-inflammatories and Adolescent Schizophrenia

Unknown
NCT03694873Phase 4

Oral Tramadol Versus Oral Celecoxib for Post-perineal Repair Analgesia

Unknown
NCT03499743Not Applicable

Celecoxib Versus Hyoscine Butyl-bromide in Reducing Pain Associated With IUD.

Completed

Drug Details

Intervention Type
DRUG
Total Trials
21